You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
啟明醫療(02500.HK)成立合資公司引進Healium新一代創新器械
阿思達克 07-02 10:02
啟明醫療(02500.HK)公布,已與以色列高科技公司Healium成立合資公司Renaly,以引進Healium的新一

代去腎交感神經術(RDN)創新器械,並將RDN產品在全球範圍內進行研發,生產及商業化。公司將會成為Renaly的控股股東。

RDN療法在治療未控制或頑固性高血壓方面具有顯著的安全性和有效性。公司指,通過今次合作,將切入高血壓介入治療領域,而高血壓與心臟瓣膜疾病的發生息息相關。董事會深信,本次合作將顯著拓展產品佈局,憑藉公司在結構性心臟病領域的研發、生產及商業化的優勢,與現有產品線形成強大的組合,為市場未滿足的臨床需求提供更佳的治療選擇。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account